Skip to content
Who we are
About us
Team
Board
Partnerships
Technology platform
Our technology
Manufacturing
Scientific publications and patents
Pipeline
Pipeline Overview
CEB-01
Clinical Trial CEB-01-RLS01-CT
Clinical Trial CEB-01-RLPC01-CT
Clinical Trial CEB-01-RLP01-CT
Investors
Invest in us
CEB-Shareholders Cebiotex
Shareholders Cebfunding
News
Contact
Who we are
About us
Team
Board
Partnerships
Technology platform
Our technology
Manufacturing
Scientific publications and patents
Pipeline
Pipeline Overview
CEB-01
Clinical Trial CEB-01-RLS01-CT
Clinical Trial CEB-01-RLPC01-CT
Clinical Trial CEB-01-RLP01-CT
Investors
Invest in us
CEB-Shareholders Cebiotex
Shareholders Cebfunding
News
Contact
Who we are
About us
Team
Board
Partnerships
Technology platform
Our technology
Manufacturing
Scientific publications and patents
Pipeline
Pipeline Overview
CEB-01
Clinical Trial CEB-01-RLS01-CT
Clinical Trial CEB-01-RLPC01-CT
Clinical Trial CEB-01-RLP01-CT
Investors
Invest in us
CEB-Shareholders Cebiotex
Shareholders Cebfunding
News
Contact
11/09/2023
CEB-01 Phase-1 clinical trial progress presented at CTOS 2023
You might also be interested in
La Vanguardia: “Ensayo de una biomembrana para tratar a recién operados de cáncer” (Spanish)
Haz clic aquí para leer el artículo:
Read more
Launch of First Pancreatic Cancer Clinical Trial with CEB-01 in Spain
We are pleased to announce our first clinical trial in
Read more
